4.2 Article

Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality

Olof Stephansson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Pharmacology & Pharmacy

Hepatic Cyp2d and Cyp26a1 mRNAs and Activities Are Increased During Mouse Pregnancy

Ariel R. Topletz et al.

DRUG METABOLISM AND DISPOSITION (2013)

Article Psychiatry

Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders

Lisa A. Croen et al.

ARCHIVES OF GENERAL PSYCHIATRY (2011)

Article Psychiatry

Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes

Katherine L. Wisner et al.

AMERICAN JOURNAL OF PSYCHIATRY (2009)

Article Pharmacology & Pharmacy

Sustained Neurobehavioral Effects of Exposure to SSRI Antidepressants During Development: Molecular to Clinical Evidence

T. F. Oberlander et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)

Article Psychology, Clinical

No Decision Is Without Risk

Rita Suri et al.

JOURNAL OF CLINICAL PSYCHIATRY (2009)

Article Public, Environmental & Occupational Health

Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn

Susan E. Andrade et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)

Editorial Material Psychology, Clinical

Balancing risks: Dosing strategies for antidepressants near the end of pregnancy

Laura J. Miller et al.

JOURNAL OF CLINICAL PSYCHIATRY (2008)

Article Psychology, Clinical

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum

Dorothy K. Sit et al.

JOURNAL OF CLINICAL PSYCHIATRY (2008)

Article Public, Environmental & Occupational Health

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn

Bengt Kallen et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)

Article Psychology, Clinical

Birth outcomes following prenatal exposure to antidepressants

Kimberly H. Pearson et al.

JOURNAL OF CLINICAL PSYCHIATRY (2007)

Article Medicine, General & Internal

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

Sura Alwan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

Carol Louik et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Pharmacology & Pharmacy

Postpartum depression - A randomized trial of sertraline versus nortriptyline

Katherine L. Wisner et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)

Article Medicine, General & Internal

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn

CD Chambers et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Pediatrics

Neonatal abstinence syndrome after in utero exposure to selective serotonin Reuptake inhibitors in term infants

R Levison-Castiel et al.

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2006)

Article Medicine, General & Internal

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment

LS Cohen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Medical Laboratory Technology

Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients

G Bondolfi et al.

THERAPEUTIC DRUG MONITORING (2005)

Review Medicine, General & Internal

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors - Literature review and implications for clinical applications

EL Moses-Kolko et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Pharmacology & Pharmacy

Antidepressant use during pregnancy and the rates of spontaneous abortions:: A meta-analysis

MEH Hemels et al.

ANNALS OF PHARMACOTHERAPY (2005)

Article Obstetrics & Gynecology

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy

TS Tracy et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)

Review Pharmacology & Pharmacy

Pregnancy-induced changes in pharmacokinetics - A mechanistic-based approach

GD Anderson

CLINICAL PHARMACOKINETICS (2005)

Article Public, Environmental & Occupational Health

Depressive symptoms among pregnant women screened in obstetrics settings

SM Marcus et al.

JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2003)

Review Pharmacology & Pharmacy

Quantitative pharmacogenetics of nortriptyline - A novel approach

EE Kvist et al.

CLINICAL PHARMACOKINETICS (2001)

Review Psychiatry

Risk-benefit decision making for treatment of depression during pregnancy

KL Wisner et al.

AMERICAN JOURNAL OF PSYCHIATRY (2000)